{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T21:06:01Z","timestamp":1776200761929,"version":"3.50.1"},"reference-count":96,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1124\/jpet.122.001529","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T20:30:11Z","timestamp":1684182611000},"page":"224-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Siponimod As a Novel Inhibitor of Retinal Angiogenesis: In Vitro and In Vivo Evidence of Therapeutic Efficacy"],"prefix":"10.1016","volume":"386","author":[{"given":"Rasha A.","family":"Alshaikh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rania Gamal Eldin","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rania A. Salah","family":"El Din","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie B.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6078-0027","authenticated-orcid":false,"given":"Christian","family":"Waeber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.122.001529_bib1","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1136\/bjophthalmol-2021-319115","article-title":"Sphingosine 1-phosphate, a potential target in neovascular retinal disease","volume":"106","author":"Alshaikh","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"10.1124\/jpet.122.001529_bib2","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2337\/db19-1121","article-title":"Claudin-5 redistribution induced by inflammation leads to anti-VEGF-resistant diabetic macular edema","volume":"69","author":"Arima","year":"2020","journal-title":"Diabetes"},{"key":"10.1124\/jpet.122.001529_bib3","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.2337\/db09-1606","article-title":"TNF-\u03b1 signals through PKC\u03b6\/NF-\u03baB to alter the tight junction complex and increase retinal endothelial cell permeability","volume":"59","author":"Aveleira","year":"2010","journal-title":"Diabetes"},{"key":"10.1124\/jpet.122.001529_bib4","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3109\/02713680903429007","article-title":"Effect of subconjunctival and intraocular bevacizumab injections on corneal neovascularization in a mouse model","volume":"35","author":"Avisar","year":"2010","journal-title":"Curr Eye Res"},{"key":"10.1124\/jpet.122.001529_bib5","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202201346R","article-title":"S1PR1 signaling attenuates apoptosis of retinal ganglion cells via modulation of cJun\/Bim cascade and Bad phosphorylation in a mouse model of glaucoma","volume":"37","author":"Basavarajappa","year":"2023","journal-title":"FASEB J"},{"key":"10.1124\/jpet.122.001529_bib6","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/glia.20324","article-title":"Sphingosine-1-phosphate is released by cerebellar astrocytes in response to bFGF and induces astrocyte proliferation through Gi-protein-coupled receptors","volume":"53","author":"Bassi","year":"2006","journal-title":"Glia"},{"key":"10.1124\/jpet.122.001529_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226302","article-title":"Isolation of endothelial cells, pericytes and astrocytes from mouse brain","volume":"14","author":"Bernard-Patrzynski","year":"2019","journal-title":"PLoS One"},{"key":"10.1124\/jpet.122.001529_bib8","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1167\/iovs.06-0570","article-title":"Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis","volume":"48","author":"Bock","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1124\/jpet.122.001529_bib9","doi-asserted-by":"crossref","first-page":"6472","DOI":"10.1167\/iovs.13-12518","article-title":"Identification of VEGF-independent cytokines in proliferative diabetic retinopathy vitreous","volume":"54","author":"Bromberg-White","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1124\/jpet.122.001529_bib10","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.bbamcr.2017.02.004","article-title":"Sphingosine 1-phosphate signaling axis mediates fibroblast growth factor 2-induced proliferation and survival of murine auditory neuroblasts","volume":"1864","author":"Bruno","year":"2017","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1124\/jpet.122.001529_bib11","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.exer.2008.07.012","article-title":"Anti-sphingosine-1-phosphate monoclonal antibodies inhibit angiogenesis and sub-retinal fibrosis in a murine model of laser-induced choroidal neovascularization","volume":"88","author":"Caballero","year":"2009","journal-title":"Exp Eye Res"},{"key":"10.1124\/jpet.122.001529_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40942-017-0084-9","article-title":"Retinal and choroidal angiogenesis: a review of new targets","volume":"3","author":"Cabral","year":"2017","journal-title":"Int J Retina Vitreous"},{"key":"10.1124\/jpet.122.001529_bib13","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/dmrr.415","article-title":"Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives","volume":"19","author":"Caldwell","year":"2003","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1124\/jpet.122.001529_bib14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","article-title":"Corneal neovascularization: an anti-VEGF therapy review","volume":"57","author":"Chang","year":"2012","journal-title":"Surv Ophthalmol"},{"key":"10.1124\/jpet.122.001529_bib15","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ajpath.2011.10.008","article-title":"Therapeutic dosing of fingolimod (FTY720) prevents cell infiltration, rapidly suppresses ocular inflammation, and maintains the blood-ocular barrier","volume":"180","author":"Copland","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1124\/jpet.122.001529_bib16","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1136\/bjophthalmol-2012-301677","article-title":"Actions of bevacizumab and ranibizumab on microvascular retinal endothelial cells: similarities and differences","volume":"96","author":"Deissler","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1124\/jpet.122.001529_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.108945","article-title":"Blocking of VEGF-A is not sufficient to completely revert its long-term effects on the barrier formed by retinal endothelial cells","volume":"216","author":"Deissler","year":"2022","journal-title":"Exp Eye Res"},{"key":"10.1124\/jpet.122.001529_bib18","first-page":"1474","article-title":"Ranibizumab vs. bevacizumab treatment of corneal neovascularization in mice","volume":"49","author":"Dratviman","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1124\/jpet.122.001529_bib19","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.prp.2011.11.008","article-title":"LPS and TNF-\u03b1 induce expression of sphingosine-1-phosphate receptor-2 in human microvascular endothelial cells","volume":"208","author":"Du","year":"2012","journal-title":"Pathol Res Pract"},{"key":"10.1124\/jpet.122.001529_bib20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3389\/fimmu.2019.00217","article-title":"Fingolimod alters tissue distribution and cytokine production of human and murine innate lymphoid cells","volume":"10","author":"Eken","year":"2019","journal-title":"Front Immunol"},{"key":"10.1124\/jpet.122.001529_bib21","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.4103\/ijo.IJO_3724_20","article-title":"Evaluation of sphingolipid metabolism on diabetic retinopathy","volume":"69","author":"Ensari Delio\u011flu","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"10.1124\/jpet.122.001529_bib22","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1167\/iovs.17-22544","article-title":"Sphingosine kinase 2 modulates retinal neovascularization in the mouse model of oxygen-induced retinopathy","volume":"59","author":"Eresch","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1124\/jpet.122.001529_bib23","doi-asserted-by":"crossref","DOI":"10.1177\/09603271221084674","article-title":"The effects of subconjunctival bevacizumab, ranibizumab, and aflibercept on corneal neovascularization","volume":"41","author":"Eski","year":"2022","journal-title":"Hum Exp Toxicol"},{"key":"10.1124\/jpet.122.001529_bib24","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.bbrc.2012.02.096","article-title":"Blocking S1P interaction with S1P1 receptor by a novel competitive S1P1-selective antagonist inhibits angiogenesis","volume":"419","author":"Fujii","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.122.001529_bib25","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1093\/ndt\/gfn352","article-title":"Thrombin enhances the production of monocyte chemoattractant protein-1 and macrophage inflammatory protein-2 in cultured rat glomerular epithelial cells","volume":"23","author":"Fujita","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1124\/jpet.122.001529_bib26","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1600-0420.2004.00312.x","article-title":"Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in the regulation of corneal neovascularization and wound healing","volume":"82","author":"Gan","year":"2004","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1124\/jpet.122.001529_bib27","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1172\/JCI12450","article-title":"Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement","volume":"108","author":"Garcia","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.122.001529_bib28","first-page":"583","article-title":"Histamine, ZO-1 and increased blood-retinal barrier permeability in diabetic retinopathy","volume":"93","author":"Gardner","year":"1995","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1124\/jpet.122.001529_bib29","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1476-5381.2012.02061.x","article-title":"The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate","volume":"167","author":"Gergely","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.122.001529_bib30","doi-asserted-by":"crossref","first-page":"13839","DOI":"10.1074\/jbc.M311743200","article-title":"Sphingosine 1-phosphate (S1P) receptor subtypes S1P 1 and S1P 3, respectively, regulate lymphocyte recirculation and heart rate","volume":"279","author":"Germana Sanna","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.122.001529_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exer.2014.02.005","article-title":"Alkali burn versus suture-induced corneal neovascularization in C57BL\/6 mice: an overview of two common animal models of corneal neovascularization","volume":"121","author":"Giacomini","year":"2014","journal-title":"Exp Eye Res"},{"key":"10.1124\/jpet.122.001529_bib32","article-title":"S1P-S1PR1 activity controls VEGF-A signaling during lymphatic vessel development","author":"Golding-Ochsenbein","year":"2019","journal-title":"bioRxiv"},{"key":"10.1124\/jpet.122.001529_bib33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12951-021-00904-6","article-title":"The targetable nanoparticle BAF312@cRGD-CaP-NP represses tumor growth and angiogenesis by downregulating the S1PR1\/P-STAT3\/VEGFA axis in triple-negative breast cancer","volume":"19","author":"Gong","year":"2021","journal-title":"J Nanobiotechnology"},{"key":"10.1124\/jpet.122.001529_bib34","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1124\/mol.108.049783","article-title":"Full pharmacological efficacy of a novel S1P1 agonist that does not require S1P-like headgroup interactions","volume":"74","author":"Gonzalez-Cabrera","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.122.001529_bib35","first-page":"911","article-title":"Long-term outcome of aflibercept subconjuctival treatment for chemical induced corneal neovascularization in the rabbit model","volume":"62","author":"Gore","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1124\/jpet.122.001529_bib36","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.130273","article-title":"Dysregulated claudin-5 cycling in the inner retina causes retinal pigment epithelial cell atrophy","volume":"4","author":"Hudson","year":"2019","journal-title":"JCI Insight"},{"key":"10.1124\/jpet.122.001529_bib37","doi-asserted-by":"crossref","first-page":"10664","DOI":"10.1073\/pnas.1934494100","article-title":"VEGF induces S1P1 receptors in endothelial cells: implications for cross-talk between sphingolipid and growth factor receptors","volume":"100","author":"Igarashi","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.122.001529_bib38","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3390\/cells9040928","article-title":"Inflammatory conditions disrupt constitutive endothelial cell barrier stabilization by alleviating autonomous secretion of sphingosine 1-phosphate","volume":"9","author":"Jeya Paul","year":"2020","journal-title":"Cells"},{"key":"10.1124\/jpet.122.001529_bib39","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000102935","article-title":"Vascular endothelial growth factor and basic fibroblast growth factor in exudative age-related macular degeneration and diffuse diabetic macular edema","volume":"39","author":"Jonas","year":"2007","journal-title":"Ophthalmic Res"},{"key":"10.1124\/jpet.122.001529_bib40","doi-asserted-by":"crossref","first-page":"7637","DOI":"10.1167\/iovs.14-15430","article-title":"Transgenic mouse models of corneal neovascularization: new perspectives for angiogenesis research","volume":"55","author":"Kather","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1124\/jpet.122.001529_bib41","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/ICO.0b013e31815cf67d","article-title":"Inhibition of experimental corneal neovascularization by using subconjunctival injection of bevacizumab (Avastin)","volume":"27","author":"Kim","year":"2008","journal-title":"Cornea"},{"key":"10.1124\/jpet.122.001529_bib42","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1042\/bj3480071","article-title":"Sphingosine 1-phosphate stimulates proliferation and migration of human endothelial cells possibly through the lipid receptors, Edg-1 and Edg-3","volume":"348","author":"Kimura","year":"2000","journal-title":"Biochem J"},{"key":"10.1124\/jpet.122.001529_bib43","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/ICO.0b013e3182801645","article-title":"Inhibition of corneal neovascularization by subconjunctival and topical bevacizumab and sunitinib in a rabbit model","volume":"32","author":"Ko","year":"2013","journal-title":"Cornea"},{"key":"10.1124\/jpet.122.001529_bib44","first-page":"705","article-title":"Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study","volume":"40","author":"Kon","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1124\/jpet.122.001529_bib45","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1177\/1947601911423654","article-title":"Hypoxia-induced angiogenesis: good and evil","volume":"2","author":"Krock","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1124\/jpet.122.001529_bib46","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1161\/01.ATV.0000154360.36106.d9","article-title":"Stable knock-down of the sphingosine 1-phosphate receptor S1P1 influences multiple functions of human endothelial cells","volume":"25","author":"Krump-Konvalinkova","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/jpet.122.001529_bib47","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/01.RES.0000259593.07661.1e","article-title":"Endothelial cell migration during angiogenesis","volume":"100","author":"Lamalice","year":"2007","journal-title":"Circ Res"},{"key":"10.1124\/jpet.122.001529_bib48","first-page":"1202","article-title":"Changes in vitreous VEGF, bFGF and fibrosis in proliferative diabetic retinopathy after intravitreal bevacizumab","volume":"8","author":"Li","year":"2015","journal-title":"Int J Ophthalmol"},{"key":"10.1124\/jpet.122.001529_bib500","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/path.4564","article-title":"Specific chemotherapeutic agents induce metastatic behaviour through stromal- and tumour-derived cytokine and angiogenic factor signalling","volume":"237","author":"Liu","year":"2015","journal-title":"J Pathol"},{"key":"10.1124\/jpet.122.001529_bib49","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/ceo.13333","article-title":"Topical axitinib is a potent inhibitor of corneal neovascularization","volume":"46","author":"Lled\u00f3 Riquelme","year":"2018","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1124\/jpet.122.001529_bib50","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1038\/eye.2017.143","article-title":"Real-world visual acuity outcomes between ranibizumab and aflibercept in treatment of neovascular AMD in a large US data set","volume":"31","author":"Lotery","year":"2017","journal-title":"Eye (Lond)"},{"key":"10.1124\/jpet.122.001529_bib501","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1038\/s41375-019-0478-9","article-title":"Sphingosine-1-phosphate signalling drives an angiogenic transcriptional programme in diffuse large B cell lymphoma","volume":"33","author":"Lupino","year":"2019","journal-title":"Leuk"},{"key":"10.1124\/jpet.122.001529_bib51","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1167\/iovs.05-1236","article-title":"Pharmacologic manipulation of sphingosine kinase in retinal endothelial cells: implications for angiogenic ocular diseases","volume":"47","author":"Maines","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1124\/jpet.122.001529_bib52","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1161\/ATVBAHA.111.235408","article-title":"Pericyte-derived sphingosine 1-phosphate induces the expression of adhesion proteins and modulates the retinal endothelial cell barrier","volume":"31","author":"McGuire","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/jpet.122.001529_bib53","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nchembio.173","article-title":"Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors","volume":"5","author":"Mullershausen","year":"2009","journal-title":"Nat Chem Biol"},{"key":"10.1124\/jpet.122.001529_bib54","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/intimm\/dxaa008","article-title":"Mechanisms of new blood-vessel formation and proliferative heterogeneity of endothelial cells","volume":"32","author":"Naito","year":"2020","journal-title":"Int Immunol"},{"key":"10.1124\/jpet.122.001529_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032167","article-title":"Morphological and functional changes in the retina after chronic oxygen-induced retinopathy","volume":"7","author":"Nakamura","year":"2012","journal-title":"PLoS One"},{"key":"10.1124\/jpet.122.001529_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121488","article-title":"Fingolimod prevents blood-brain barrier disruption induced by the sera from patients with multiple sclerosis","volume":"10","author":"Nishihara","year":"2015","journal-title":"PLoS One"},{"key":"10.1124\/jpet.122.001529_bib57","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.tips.2013.05.002","article-title":"The structure and function of the S1P1 receptor","volume":"34","author":"O\u2019Sullivan","year":"2013","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.122.001529_bib58","doi-asserted-by":"crossref","first-page":"11830","DOI":"10.1074\/jbc.M009422200","article-title":"Sphingosine 1-phosphate-induced endothelial cell migration requires the expression of EDG-1 and EDG-3 receptors and Rho-dependent activation of \u03b1 vbeta3- and \u03b21-containing integrins","volume":"276","author":"Paik","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.122.001529_bib59","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/ICO.0000000000000507","article-title":"Inhibitory effect of topical aflibercept on corneal neovascularization in rabbits","volume":"34","author":"Park","year":"2015","journal-title":"Cornea"},{"key":"10.1124\/jpet.122.001529_bib60","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1177\/0271678X20943823","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"40","author":"Percie du Sert","year":"2020","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1124\/jpet.122.001529_bib61","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1007\/s00204-018-2189-9","article-title":"Induction of hemangiosarcoma in mice after chronic treatment with S1P-modulator siponimod and its lack of relevance to rat and human","volume":"92","author":"Pognan","year":"2018","journal-title":"Arch Toxicol"},{"key":"10.1124\/jpet.122.001529_bib62","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.3390\/ijms19123885","article-title":"Characterizing sphingosine kinases and sphingosine 1-phosphate receptors in the mammalian eye and retina","volume":"19","author":"Porter","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1124\/jpet.122.001529_bib63","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1172\/JCI76369","article-title":"Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy","volume":"125","author":"Proia","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.122.001529_bib64","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.21037\/atm-20-4368","article-title":"Reconstruction of the ocular surface by autologous transplantation of rabbit adipose tissue-derived stem cells on amniotic membrane","volume":"8","author":"Qiu","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1124\/jpet.122.001529_bib65","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1161\/hq0102.101843","article-title":"Involvement of endothelial nitric oxide in sphingosine-1-phosphate-induced angiogenesis","volume":"22","author":"Rikitake","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/jpet.122.001529_bib66","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fphar.2011.00009","article-title":"Selectivity and specificity of sphingosine-1-phosphate receptor ligands: caveats and critical thinking in characterizing receptor-mediated effects","volume":"2","author":"Salomone","year":"2011","journal-title":"Front Pharmacol"},{"key":"10.1124\/jpet.122.001529_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173262","article-title":"Bone regenerative potential of the selective sphingosine 1-phosphate receptor modulator siponimod: In vitro characterisation using osteoblast and endothelial cells","volume":"882","author":"Sartawi","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.122.001529_bib68","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/jcb.21181","article-title":"The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1","volume":"101","author":"Schmid","year":"2007","journal-title":"J Cell Biochem"},{"key":"10.1124\/jpet.122.001529_bib69","doi-asserted-by":"crossref","first-page":"29454","DOI":"10.3390\/ijms161226177","article-title":"Fingolimod (FTY720-P) does not stabilize the blood\u2013brain barrier under inflammatory conditions in an in vitro model","volume":"16","author":"Schuhmann","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1124\/jpet.122.001529_bib70","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s40263-020-00771-z","article-title":"Siponimod: a review in secondary progressive multiple sclerosis","volume":"34","author":"Scott","year":"2020","journal-title":"CNS Drugs"},{"key":"10.1124\/jpet.122.001529_bib71","doi-asserted-by":"crossref","first-page":"7758","DOI":"10.1128\/MCB.22.22.7758-7768.2002","article-title":"Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases","volume":"22","author":"Shu","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1124\/jpet.122.001529_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019475","article-title":"Enhancement of neoangiogenesis and follicle survival by sphingosine-1-phosphate in human ovarian tissue xenotransplants","volume":"6","author":"Soleimani","year":"2011","journal-title":"PLoS One"},{"key":"10.1124\/jpet.122.001529_bib73","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.3390\/biom12091174","article-title":"Microglia contributes to BAF-312 effects on blood-brain barrier stability","volume":"12","author":"Spampinato","year":"2022","journal-title":"Biomolecules"},{"key":"10.1124\/jpet.122.001529_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114465","article-title":"Protective effect of the sphingosine-1 phosphate receptor agonist siponimod on disrupted blood brain barrier function","volume":"186","author":"Spampinato","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.122.001529_bib75","first-page":"134","article-title":"TNF-alpha level in the vitreous body. Increase in neovascular eye diseases and proliferative diabetic retinopathy","volume":"90","author":"Spranger","year":"1995","journal-title":"Med Klin (Munich)"},{"key":"10.1124\/jpet.122.001529_bib76","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/2211068214561025","article-title":"TEER measurement techniques for in vitro barrier model systems","volume":"20","author":"Srinivasan","year":"2015","journal-title":"J Lab Autom"},{"key":"10.1124\/jpet.122.001529_bib77","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7","article-title":"Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study","volume":"9","author":"Steinmetz","year":"2021","journal-title":"Lancet Glob Health"},{"key":"10.1124\/jpet.122.001529_bib78","doi-asserted-by":"crossref","first-page":"8232","DOI":"10.1167\/iovs.14-14217","article-title":"Modulation of VEGF-induced retinal vascular permeability by peroxisome proliferator-activated receptor-\u03b2\/\u03b4","volume":"55","author":"Suarez","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1124\/jpet.122.001529_bib79","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s10384-011-0004-8","article-title":"Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion","volume":"55","author":"Suzuki","year":"2011","journal-title":"Jpn J Ophthalmol"},{"key":"10.1124\/jpet.122.001529_bib80","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1111\/j.1582-4934.2010.01136.x","article-title":"Vascular biology: the role of sphingosine 1-phosphate in both the resting state and inflammation","volume":"14","author":"Swan","year":"2010","journal-title":"J Cell Mol Med"},{"key":"10.1124\/jpet.122.001529_bib81","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1124\/pr.107.07113","article-title":"\u201cInside-out\u201d signaling of sphingosine-1-phosphate: therapeutic targets","volume":"60","author":"Takabe","year":"2008","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.122.001529_bib82","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.intimp.2011.07.004","article-title":"The sphingosine-1-phosphate receptor-1 antagonist, W146, causes early and short-lasting peripheral blood lymphopenia in mice","volume":"11","author":"Tarras\u00f3n","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"10.1124\/jpet.122.001529_bib83","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.3390\/ijms20153670","article-title":"Light stress-induced increase of sphingosine 1-phosphate in photoreceptors and its relevance to retinal degeneration","volume":"20","author":"Terao","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1124\/jpet.122.001529_bib84","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1038\/s41433-020-01347-3","article-title":"Intrastromal versus subconjunctival anti-VEGF agents for treatment of corneal neovascularization: a rabbit study","volume":"35","author":"Ucgul","year":"2021","journal-title":"Eye (Lond)"},{"key":"10.1124\/jpet.122.001529_bib85","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3390\/cells10051049","article-title":"Anti-VEGF-resistant retinal diseases: a review of the latest treatment options","volume":"10","author":"Wallsh","year":"2021","journal-title":"Cells"},{"key":"10.1124\/jpet.122.001529_bib86A","article-title":"Vitreous and plasma VEGF levels as predictive factors in the progression of proliferative diabetic retinopathy after vitrectomy","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/jpet.122.001529_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-022-05210-z","article-title":"S1PR1 induces metabolic reprogramming of ceramide in vascular endothelial cells, affecting hepatocellular carcinoma angiogenesis and progression","volume":"13","author":"Wang","year":"2022","journal-title":"Cell Death Dis"},{"key":"10.1124\/jpet.122.001529_bib87","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.bbalip.2014.06.012","article-title":"The role of sphingosine-1-phosphate in endothelial barrier function","volume":"1841","author":"Wilkerson","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.122.001529_bib88","first-page":"85","article-title":"S1P control of endothelial integrity","volume":"378","author":"Xiong","year":"2014","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1124\/jpet.122.001529_bib89","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0021-9150(02)00100-4","article-title":"D-erythro-N,N-dimethylsphingosine inhibits bFGF-induced proliferation of cerebral, aortic and coronary smooth muscle cells","volume":"164","author":"Xu","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1124\/jpet.122.001529_bib90","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1073\/pnas.1618659114","article-title":"Size-selective opening of the blood-brain barrier by targeting endothelial sphingosine 1-phosphate receptor 1","volume":"114","author":"Yanagida","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.122.001529_bib91","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3389\/fimmu.2017.00925","article-title":"DT-13 ameliorates TNF-\u03b1-induced vascular endothelial hyperpermeability via non-muscle myosin IIA and the Src\/PI3K\/Akt signaling pathway","volume":"8","author":"Zhang","year":"2017","journal-title":"Front Immunol"},{"key":"10.1124\/jpet.122.001529_bib92","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s10753-018-0918-0","article-title":"ApoM-S1P modulates ox-LDL-induced inflammation through the PI3K\/Akt signaling pathway in HUVECs","volume":"42","author":"Zheng","year":"2019","journal-title":"Inflammation"},{"key":"10.1124\/jpet.122.001529_bib93","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fphar.2020.00059","article-title":"Non-mitogenic fibroblast growth factor 1 enhanced angiogenesis following ischemic stroke by regulating the sphingosine-1-phosphate 1 pathway","volume":"11","author":"Zou","year":"2020","journal-title":"Front Pharmacol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524170681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524170681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.122.001529","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T13:30:35Z","timestamp":1739971835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524170681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":96,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0022356524170681"],"URL":"https:\/\/doi.org\/10.1124\/jpet.122.001529","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Siponimod As a Novel Inhibitor of Retinal Angiogenesis: In Vitro and In Vivo Evidence of Therapeutic Efficacy","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.122.001529","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}